Houston, TXNCT07207876Now EnrollingIRB Ready

Pregnancy Clinical Trial in Houston, TX

Access cutting-edge pregnancy treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access pregnancy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pregnancy treatment provided free

Apply for This Houston Location

Check if you qualify for this pregnancy clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Pregnancy Study in Houston

IMPAACT 2044 is a study to characterize the pharmacokinetics (PK) and safety of ceftriaxone and benzathine penicillin G during pregnancy. Up to 78 pregnant women receiving (1) ceftriaxone for indications other than syphilis or (2) benzathine penicillin G for treatment of syphilis from non-study clinical care providers will be enrolled at study sites located in the United States. Approximately 22 infants of pregnant participants receiving benzathine penicillin G will also be enrolled.

Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Who Can Participate

Inclusion Criteria

Is of legal age or circumstance to provide independent informed consent as determined by site standard operating procedures (SOPs) and consistent with Institutional Review Board (IRB) policies and procedures and is willing and able to provide written informed consent for her own and, if applicable (Arm 2), her infant's study participation
At screening, has a viable singleton intrauterine pregnancy of any gestational age confirmed by fetal ultrasound, as determined by the site investigator based on medical records, with trimester documented based on the best available obstetric estimate
At screening, is receiving or expected to receive one of the following drugs under study as prescribed by a clinical care provider and documented in medical records:
Ceftriaxone: IV or IM administration for an indication other than syphilis
Benzathine penicillin G: IM administration for treatment of syphilis
At entry, expects to remain in the geographic area of the study site during pregnancy and at least 30 days postpartum

Exclusion Criteria

Previously enrolled in this study
Requires desensitization to ceftriaxone or benzathine penicillin G as determined by the site investigator based on pregnant participant report and available medical records
Has any of the following as determined by the site investigator based on pregnant participant report and available medical records:
Current indication for hemodialysis
Current indication for intensive care unit hospitalization
Creatinine (Cr) ≥ 3.5 x upper limit of normal (ULN) at any time during the current pregnancy and/or chronic kidney disease Stage 5
Receipt of any of the following prohibited medications within seven days prior to entry as determined by the site investigator based on pregnant participant report and available medical records:
Arm 1A: any penicillin
Arm 1B: any penicillin
Arm 2: penicillin other than benzathine penicillin G
Chlorpropamide
Ketorolac tromethamine
Meclofenamic acid
Mefenamic acid
Penciclovir
Pioglitazone
Telmisartan
Receipt of any investigational agent within seven days prior to entry as determined by the site investigator based on pregnant participant report and available medical records
Has any documented or suspected clinically significant condition that, in the opinion of the site investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving study objectives

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT07207876) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pregnancy Treatment Options in Houston, TX

If you're searching for pregnancy treatment options in Houston, TX, this clinical trial (NCT07207876) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pregnancy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pregnancy clinical trials near you to find additional studies recruiting in your area.

More Preeclampsia Trials in Houston, TX

See all preeclampsia clinical trials recruiting in Houston — not just this study.

Browse Preeclampsia Trials in Houston →

Browse More Trials by Condition

Preeclampsia TrialsGestational Diabetes TrialsPemphigoid Gestationis TrialsRecurrent Pregnancy Loss TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX